Lisata Therapeutics Statistics

Total Valuation

LON:0HS8 has a market cap or net worth of GBP 29.46 million. The enterprise value is 15.33 million.

Market Cap	29.46M
Enterprise Value	15.33M

Important Dates

The next estimated earnings date is Friday, February 27, 2026.

Earnings Date	Feb 27, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	8.82M
Shares Outstanding	n/a
Shares Change (YoY)	+3.87%
Shares Change (QoQ)	+1.55%
Owned by Insiders (%)	19.91%
Owned by Institutions (%)	8.24%
Float	7.06M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	37.01
PB Ratio	2.31
P/TBV Ratio	2.30
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.13
EV / Sales	19.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.19

Financial Position

The company has a current ratio of 4.72

Current Ratio	4.72
Quick Ratio	4.42
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -72.17% and return on invested capital (ROIC) is -49.47%.

Return on Equity (ROE)	-72.17%
Return on Assets (ROA)	-41.86%
Return on Invested Capital (ROIC)	-49.47%
Return on Capital Employed (ROCE)	-116.80%
Weighted Average Cost of Capital (WACC)	11.26%
Revenue Per Employee	30,616
Profits Per Employee	-521,960
Employee Count	26
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	-715,670
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +81.28% in the last 52 weeks. The beta is 1.28, so LON:0HS8's price volatility has been higher than the market average.

Beta (5Y)	1.28
52-Week Price Change	+81.28%
50-Day Moving Average	2.92
200-Day Moving Average	2.84
Relative Strength Index (RSI)	73.06
Average Volume (20 Days)	4,279

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	0.19

Income Statement

In the last 12 months, LON:0HS8 had revenue of GBP 796,016 and -13.57 million in losses. Loss per share was -1.58.

Revenue	796,016
Gross Profit	796,016
Operating Income	-14.94M
Pretax Income	-14.29M
Net Income	-13.57M
EBITDA	-14.81M
EBIT	-14.94M
Loss Per Share	-1.58

Full Income Statement

Balance Sheet

The company has 14.13 million in cash and n/a in debt, with a net cash position of 14.13 million.

Cash & Cash Equivalents	14.13M
Total Debt	n/a
Net Cash	14.13M
Net Cash Per Share	n/a
Equity (Book Value)	12.74M
Book Value Per Share	1.48
Working Capital	12.65M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -12.82 million and capital expenditures -20,830, giving a free cash flow of -12.84 million.

Operating Cash Flow	-12.82M
Capital Expenditures	-20,830
Free Cash Flow	-12.84M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-1,876.54%
Pretax Margin	-1,794.77%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LON:0HS8 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.87%
Shareholder Yield	-3.87%
Earnings Yield	-46.06%
FCF Yield	-43.57%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 15, 2022. It was a reverse split with a ratio of 0.0666666667.

Last Split Date	Sep 15, 2022
Split Type	Reverse
Split Ratio	0.0666666667

Scores

LON:0HS8 has an Altman Z-Score of -35.32 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-35.32
Piotroski F-Score	1